Post Transplant Lymphoproliferative Disease News and Research

RSS
Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

Single gene found to control growth of some cancers

Single gene found to control growth of some cancers

CellCept linked to reduced cancer incidence

CellCept linked to reduced cancer incidence

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.